Skip to content

Study on the prediction of cardiovascular risk in urcmic hemodialysis patients by artificial intelligence based on multi-omics of gut microbiota

Study on the prediction of cardiovascular risk in urcmic hemodialysis patients by artificial intelligence based on multi-omics of gut microbiota

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400080425
Enrollment
Unknown
Registered
2024-01-29
Start date
2023-08-21
Completion date
Unknown
Last updated
2024-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hemodialysis

Interventions

Comorbid cardiovascular disease uremic non hemodialysis patients:None
Non hemodialysis patients without vascular disease uremia:None
Comorbid cardiovascular disease uremic hemodialysis patients:None
Hemodialysis patients without vascular disease uremia:None

Sponsors

First Medical Center of Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. = 18 years old with gender unlimited; 2. Diagnosed with uremia; 3. Hemodialysis patients are required to meet regular hemodialysis for at least 3 months.

Exclusion criteria

Exclusion criteria: 1. Oncology patients; 2. Severe infection; 3. Patients taking glucocorticoids or anti-inflammatory drugs (within 1 month); 4. Infectious disease infections such as hepatitis B or C.

Design outcomes

Primary

MeasureTime frame
Intestinal flora;Gut microbiota metabolites;Echocardiogram;

Secondary

MeasureTime frame
Red blood cell count;Hemoglobin quantification;White blood cell count;Five classifications of white blood cells;Platelet count;Aspartate aminotransferase;Alanine aminotransferase;Creatine kinase;Urea;Creatinine;Uric acid;Glucose;Lactic dehydrogenase;Alkaline phosphatase;a-hydroxybutyrate dehydrogenase;Total protein;Albumin;Potassium;sodium ion;Chloride ion;Calcium ion;Magnesium ion;

Countries

China

Contacts

Public ContactHanyu Zhu

First Medical Center of Chinese PLA General Hospital

kidney301@126.com+86 139 1170 5956

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026